A globally diversified stock only portfolio with moderate risk and a tilt toward innovation driven growth

Report created on Oct 7, 2024

Risk profile Info

4/7
Balanced
Less risk More risk

Diversification profile Info

4/5
Broadly Diversified
Less diversification More diversification

Positions

This portfolio is built from four broad stock ETFs, with around three fifths in a global developed fund and the rest tilted toward emerging markets, Pacific exposure, and biotechnology. Compared with a simple global stock benchmark, this setup leans slightly more into specific regions and one thematic area. That structure matters because it shapes how the portfolio reacts to different economic cycles and policy changes. To keep things aligned with a balanced risk profile, it could help to check whether the 10 percent tilt into a single niche theme still matches your comfort level, and consider gradually adjusting weights if one holding grows far beyond its intended share.

Growth Info

Historically, this mix has delivered an annual growth rate, or CAGR, of about 8.99 percent, meaning a hypothetical 10,000 dollars could have grown to roughly 24,000 dollars over a long stretch if that rate persisted. A maximum drawdown of about minus 25 percent shows that at its worst point, the portfolio temporarily lost a quarter of its value before recovering. This is consistent with a stock only mix and aligns reasonably with global equity behavior. While this outcome looks solid, history is only one guide, so it’s useful to stress test your comfort by imagining how you’d feel during another similar drawdown.

Projection Info

The Monte Carlo analysis ran 1,000 simulations using historical return patterns to project possible future paths. Monte Carlo is basically a “what if” engine that shuffles past ups and downs in many random combinations to see a range of outcomes rather than a single guess. Here, the median result shows more than doubling over the horizon, but the 5th percentile suggests you could still see a loss of almost 30 percent. Around 87 percent of paths were positive, which is encouraging yet not a guarantee. It can be useful to plan based on the more conservative end of that range so surprises are less likely to derail long term goals.

Asset classes Info

  • Stocks
    100%

All assets sit in stocks, with no built in exposure to cash or bonds. For growth focused investors, this clear equity tilt can be appealing and has historically rewarded patience, but it also means there is no natural cushion when markets fall. Many broad benchmarks for balanced risk profiles usually include some defensive assets to smooth the ride. This portfolio’s classification as broadly diversified mainly refers to diversity within stocks, not across asset types. One option to manage emotional and financial risk is deciding in advance whether to add a modest slice of lower volatility assets outside this portfolio to serve as dry powder and a stabilizer.

Sectors Info

  • Technology
    23%
  • Financials
    20%
  • Health Care
    17%
  • Industrials
    9%
  • Consumer Discretionary
    8%
  • Telecommunications
    7%
  • Basic Materials
    5%
  • Consumer Staples
    4%
  • Energy
    3%
  • Real Estate
    2%
  • Utilities
    2%

Sector exposure is well spread across technology, financial services, healthcare, industrials, consumer areas, and more, which is a strong sign of internal diversification. Technology at about 23 percent and healthcare at 17 percent create a healthy tilt toward innovation and defensive growth. This aligns closely with common global stock benchmarks, so the mix does not appear wildly concentrated in any one economic area. However, the dedicated biotechnology ETF does slightly amplify healthcare and can increase volatility, especially around regulatory news or clinical trial outcomes. Keeping an eye on whether this thematic piece stays near 10 percent can help maintain a balanced sector profile over time.

Regions Info

  • North America
    55%
  • Asia Developed
    13%
  • Europe Developed
    11%
  • Australasia
    11%
  • Asia Emerging
    4%
  • Japan
    3%
  • Africa/Middle East
    2%
  • Latin America
    2%

Geographically, the portfolio is truly global, with just over half in North America and the rest spread across developed Europe, developed Asia, Australasia, and emerging regions. This allocation is well balanced and aligns closely with global standards, which helps reduce the risk of any single country or region driving overall results. The modest tilt toward Asia developed and emerging markets adds potential growth and diversification, but can also introduce extra swings tied to currency shifts and local politics. Periodically comparing regional weights to a global market map is a simple way to see whether any area has drifted too far from your comfort zone after strong rallies or selloffs.

Market capitalization Info

  • Mega-cap
    46%
  • Large-cap
    35%
  • Mid-cap
    15%
  • Small-cap
    2%
  • Micro-cap
    1%

The market cap breakdown leans heavily toward mega and big companies, with smaller slices in mid, small, and micro caps. Large firms tend to offer more stability, stronger balance sheets, and better liquidity, which is why they dominate broad benchmarks. This allocation matches that pattern and is generally supportive of smoother performance compared to a small cap heavy tilt. The limited but present exposure to smaller companies adds some growth potential and diversification without overwhelming risk. If you ever feel returns are lagging fast moving niches, remember that this tilt toward giants is intentional and usually fits a balanced risk profile focused on staying invested comfortably.

Risk vs. return

This chart shows the Efficient Frontier, calculated using your current assets with different allocation combinations. It highlights the best balance between risk and return based on historical data. "Efficient" portfolios maximize returns for a given risk or minimize risk for a given return. Portfolios below the curve are less efficient. This is informational and not a recommendation to buy or sell any assets.

Click on the colored dots to explore allocations.

From a risk and return perspective, this stock only mix appears reasonably close to an efficient frontier built from its current ingredients. The efficient frontier is simply the set of allocations that offer the best possible trade off between volatility and expected return using the same building blocks. Efficiency in this sense does not judge other goals like income or simplicity, only the risk return balance. Within this structure, shifting modestly between the broad global fund, the regional tilts, and the biotech slice could fine tune volatility without changing the overall character. Any changes would mainly be about smoothing the ride rather than chasing higher raw returns.

Dividends Info

  • iShares MSCI Emerging Markets ex China 2.40%
  • iShares MSCI Pacific ex Japan ETF 3.60%
  • Invesco Nasdaq Biotechnology ETF 0.80%
  • iShares MSCI World ETF 1.30%
  • Weighted yield (per year) 1.76%

The overall dividend yield sits around 1.76 percent, which is normal for a globally diversified stock mix with a tilt toward growth and biotech. Dividends are the cash payments some companies make to shareholders, and they can provide a modest return stream even when prices move sideways. The higher yields in some regional funds help offset the very low payouts from the biotechnology slice. For someone focusing mainly on growth, this is a reasonable balance. If income becomes a bigger focus later, it might be useful to evaluate whether a slightly higher yielding mix elsewhere in your broader finances could complement this growth oriented stock allocation.

Ongoing product costs Info

  • iShares MSCI Emerging Markets ex China 0.25%
  • iShares MSCI Pacific ex Japan ETF 0.48%
  • Invesco Nasdaq Biotechnology ETF 0.19%
  • iShares MSCI World ETF 0.24%
  • Weighted costs total (per year) 0.27%

Total ongoing costs, with a blended expense ratio around 0.27 percent, are impressively low and very competitive for a diversified ETF based portfolio. Fees quietly eat into returns every year, so keeping them small is one of the few levers investors fully control. This cost level aligns with best practices and supports better long term performance compared with higher fee alternatives. It’s still worth checking every year that no higher cost products have slipped in and that cheaper, similar quality options have not emerged. Maintaining this fee discipline over decades can add up to a meaningful difference in ending portfolio value.

What next?

Ready to invest in this portfolio?

Select a broker that fits your needs and watch for low fees to maximize your returns.

Select broker

Create your own report?

Analyze your portfolio

Join our community!

Join Discord

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.

Help us improve Insightfolio

Your feedback makes a difference! Share your thoughts in our quick survey. Take the survey